Hookipa Biotech

www.hookipabiotech.com

Helmut-Qualtinger-Gasse 2
Vienna
1030
Austria

+43 1 890 63 60

Activities

Pharmaceutical

Related Companies

Related Content

Hookipa achieves $10 million towards immunotherapy for KRAS-mutated cancers
Hookipa achieves $10 million towards immunotherapy for KRAS-mutated cancers
FDA accepts HOOKIPA’s IND application for HB-300 for the treatment of metastatic castration-resistant prostate cancer
FDA accepts HOOKIPA’s IND application for HB-300 for the treatment of metastatic castration-resistant prostate cancer
Hookipa and Gilead amend HIV immunotherapy agreement
Hookipa and Gilead amend HIV immunotherapy agreement
Hookipa announces clinical collaboration with Merck USA
Hookipa announces clinical collaboration with Merck USA
Hookipa Gilead collaboration reaches major milestones
Hookipa Gilead collaboration reaches major milestones
Dr Jan van de Winkel joins Hookipa as Chairman of its Board of Directors
Dr Jan van de Winkel joins Hookipa as Chairman of its Board of Directors
Reinhard Kandera appointed CFO of Hookipa Biotech
Reinhard Kandera appointed CFO of Hookipa Biotech
Hookipa appoints new Global Head R&D
Hookipa appoints new Global Head R&D
Hookipa publication highlights vaxwave as an effective viral vector for vaccination against congenital cytomegalovirus infections
Hookipa publication highlights vaxwave as an effective viral vector for vaccination against congenital cytomegalovirus infections
Dr Torsten Mummenbrauer appointed SVP Business Development & Licensing of Hookipa Biotech
Dr Torsten Mummenbrauer appointed SVP Business Development & Licensing of Hookipa Biotech